Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
Previous work has reported relatively increased Firmicutes and Proteobacteria and decreased Bacteroidetes in mice on an HFD, regardless of concomitant obesity (weight gain was minimized using a RELM knockout mouse 78 ) 78,79
Marketed as a fatburning peptide, AOD9604 claims to accelerate fat breakdown, improve metabolic flexibility, and support body recomposition
The EGD showed mildly active esophagitis
* Formulation may very slightly due to availability
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
